Aspire BioPharma, Inc. is trading at $5.97 (5.7% up) today as shares stage a technical recovery following a sharp selloff triggered by its recent acquisition announcement.
- The stock is extending a rebound after falling approximately 19% last week on heavy volume.
- Shares previously dropped 17.33% between June 8–12 after the company agreed to acquire Dura Driver Control Systems for $30 million in cash, a move that drew significant market skepticism.
- Today's price action suggests investors are reassessing the initial negative reaction to the diversification into the automotive sector.